4//SEC Filing
ISAACS STEPHEN T 4
Accession 0001140361-18-023077
CIK 0001435049other
Filed
May 10, 8:00 PM ET
Accepted
May 11, 5:00 PM ET
Size
13.5 KB
Accession
0001140361-18-023077
Insider Transaction Report
Form 4
ISAACS STEPHEN T
DirectorPresident and CEO
Transactions
- Exercise/Conversion
Common Stock
2018-05-09$0.82/sh+5,688$4,664→ 211,434 total - Exercise/Conversion
Common Stock
2018-05-09$1.00/sh+34,312$34,312→ 245,746 total - Sale
Common Stock
2018-05-09$8.01/sh−40,000$320,348→ 205,746 total - Exercise/Conversion
Stock Option (right to buy)
2018-05-09−5,688→ 0 totalExercise: $0.82Exp: 2023-11-26→ Common Stock (5,688 underlying) - Exercise/Conversion
Stock Option (right to buy)
2018-05-09−34,312→ 866,479 totalExercise: $1.00Exp: 2024-07-30→ Common Stock (34,312 underlying)
Holdings
- 8,932(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 16, 2017.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.95 to $8.125, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]The shares owned directly by the Isaacs-MacBride Family Trust UAD 03/09/01, for which the Reporting Person is a trustee.
- [F4]The shares subject to the Option are fully vested and immediately exercisable.
- [F5]The shares subject to the Option vest in 48 equal monthly installments from the vesting commencement date of July 31, 2014.
Documents
Issuer
ADURO BIOTECH, INC.
CIK 0001435049
Entity typeother
Related Parties
1- filerCIK 0001193201
Filing Metadata
- Form type
- 4
- Filed
- May 10, 8:00 PM ET
- Accepted
- May 11, 5:00 PM ET
- Size
- 13.5 KB